Literature DB >> 10671890

Schistosoma haematobium infection in children in Britain.

M Samuel1, D Misra, V Larcher, E Price.   

Abstract

OBJECTIVE: To highlight the existence of Schistosoma haematobium in certain ethnic minority groups in Britain and in English citizens who have recently visited Africa and the Middle East, so that general practitioners and paediatric nephrologists/urologists are aware of its occurrence and consider it among the differential diagnoses in children presenting with haematuria. PATIENTS AND METHODS: Over a 2-year period, six consecutive boys (mean age 13.5 years, range 8-15) presented with haematuria and were subsequently diagnosed to be infected with S. haematobium. All patients were from Africa and had recently visited their native country. There had all reported paddling in freshwater lakes and streams.
RESULTS: Dysuria and haematuria was noted 2-3 months after the infection. Terminal urine samples taken after exercise at midday were positive for S. haematobium ova. Praziquantel anti-schistosomal chemotherapy was effective in treating the infection.
CONCLUSION: S. haematobium infection is treatable in the early stages and the changes are reversible before the development of fibrotic lesions, which may result in anatomical obstruction. A terminal urine sample taken at midday after exercise was diagnostic in showing Schistosoma ova in all cases. This infection must be considered in the differential diagnoses of haematuria in some ethnic minority British citizens and in those Britons who have visited Africa or the Middle East in the recent past.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10671890     DOI: 10.1046/j.1464-410x.2000.00477.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  1 in total

1.  An unusual cause of terminal hematuria in a child: Eosinophilic cystitis.

Authors:  Elif Bahat Ozdoğan; Seçil Arslansoyu Çamlar; Sevcan Bilen; Mustafa Imamoğlu; Sükran Tıraş; Ayşegül Cansu; Yavuz Ozoran
Journal:  Can Urol Assoc J       Date:  2014-11       Impact factor: 1.862

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.